VRAX

Conviction 76HealthcareScan · Mon, Jul 20, 2026

VRAX$3.91+3.17%

ResistanceSupportVol 14

Vol MA14 6.43M

Apr 20May 6May 26Jun 11Jul 1Jul 20

Virax Biolabs Group LtdIn Vitro & In Vivo Diagnostic Substanceswww.viraxbiolabs.com ↗

Price3.91

Change+3.17%

Gap-2.90%

Rel volume0.00×

Avg volume4.76M

Avg $ vol26.52M

SMA 202.92

SMA 501.29

SMA 2000.5775

Price vs 50+203.67%

Price vs 200+577.00%

MA stackbullish

50/200 cross—

Supertrenddown · 7.07

RSI (14)61

MACD hist-0.02

MACD crossbear · 0d

Stoch %K / %D13 / 12

ADX (14)57

+DI / −DI61 / 15

RSI divergenceBearish

MACD divergence—

ATR %+24.28%

ADR %21.78%

52w high6.36

52w low0.1041

From 52w high-38.52%

Above 52w low+3656.00%

New 52w highNo

SqueezeOff

Bollinger width215.04%

%B0.66

Donchian pos28.99%

Donchian high13.19

Donchian low0.1220

AVWAP (52w high)7.64

vs AVWAP high-48.79%

AVWAP (52w low)0.6738

vs AVWAP low+480.26%

OBV trendUp

Chaikin MF (20)-0.65

Today vs 20d0.00×

Avg vol (14d)6.43M

Avg vol (20d)4.76M

Avg $ vol (20d)26.52M

Market cap2.26M

RS 3m (vs SPY)+2395.72%

RS 6m (vs SPY)+1029.79%

RS line new highNo

Trend template7/8

Technical rank99.2

1 week-3.93%

1 month+2213.61%

3 months+2508.41%

6 months+1145.22%

1 year+325.00%

YTD+918.23%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target—

Target upside—

Analyst rating—

Institutional4.62%

Ent. value2.26M

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryIn Vitro & In Vivo Diagnostic Substances

ExchangeNasdaq

Shares out4.34M

Employees19

ListedThu, Jul 21, 2022

Free float7.02M

Float %94.5%

Short interest60.62K

Days to cover0.4d

Short volume57.2%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction76 / 100

Pattern quality—

Tech rank99.2 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.97

Support0.1385

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in VRAX

All disclosures →

No recent disclosed trades by Congress in VRAX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VRAX

No recent insider (Form 4) filings in VRAX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in VRAX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.